4536 Santen Pharmaceutical
- 1529.0
- +6.0+0.39%
Santen Pharmaceutical News
List of Unrivaled Stocks (Part 1) [Ichimoku Equilibrium Chart/Kumoku Stock List]
○Kumagai Stock List Market Code Stock Name Closing Price Advance Span A Advance Span B Tokyo Stock Exchange Prime ＜1820＞ Nishimatsuken 4543 4488.5 4282 ＜1860＞ Todaken 1020 1005.25 988.5 ＜1861＞ Kumagai Gumi 4130 4102.5 4010 ＜1934＞
Taisei Corporation, Toa Road Industries, etc. (Part 1)
＜1801＞Taisei Corporation Mizuho Bank, Ltd. Stock Ownership Ratio 5.35% → 4.33% Reporting Obligation Date 2024/04/15 ＜1882＞Toa Road Industries Co., Ltd. Sumitomo Mitsui DS Asset Management Co., Ltd. Stock Ownership Ratio -% → 5.09% Reporting Obligation Date 2024/04/15 ＜1926＞Light Industries, Ltd. Sumitomo Mitsui DS Asset Management Co., Ltd. Stock Ownership Ratio 7.10% → 6.3
Convertible Stock List (Part 1) [Parabolic Signal Convertible Stock List]
○ Purchase conversion stock list market code stock name closing price SAR Tokyo Stock Exchange Prime ＜2053＞ Chubu Feed 1173 1080 ＜2109＞ DM Mitsui Sugar 3025 2937 ＜2266＞ Rokko Butter 1453 1395 ＜2294＞ Kakiyasu Main Store 3180 3090 ＜2590＞ dyDo
Express News | Silchester Owns 5.02% Stake in Santen Pharmaceutical Co - Filing
10th International TFOS Conference on the Tear Film and Ocular Surface: Basic Science and Clinical Relevance Announced
BOSTON, April 11, 2024 /PRNewswire/ -- The Tear Film & Ocular Surface Society (TFOS), a world leader in eye health research and education, has announced the "10th International TFOS Conference on the
Convertible Stock List (Part 2) [Parabolic Signal Convertible Stock List]
○List of sales conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime ＜1662＞ Petroleum Resources 6660 6960 ＜1726＞ Br. HD 370 389 ＜1812＞ Kashima 3073 3213 ＜1821＞ Misumi Kensetsu 420 460 ＜1870＞ Yahagi Ken
List of Unrivaled Stocks (Part 2) [Ichimoku Equilibrium Chart/Kumoku Stock List]
○Kumo Stock List Market Code Stock Name Closing Price Advance Span A Advance Span B Tokyo Stock Exchange Prime ＜1762＞ Takamatsu G 2771 2784.25 2803.5 ＜1808＞ Haseko 1874 1900 1885 ＜1821＞ Misumi Kensetsu 420 426 424 ＜2053＞ Chubu Feed
Stocks that moved the day before part 1 regional newspapers, TORICO, Omron, etc.
<コード>Stock name 1-day closing price ⇒ Claudia ＜3607＞ 445 +22 first half operating income increased 30.2% compared to the previous day. Mitachi ＜3321＞ 1143-92 cumulative operating profit for the 3rd quarter decreased by 41.9%. Energy Change ＜4169＞ submitted an application for approval to extend the deadline for submitting securities reports for the fiscal year ending 585-10023/12. Regional newspaper company ＜2164＞ 631 +10024 turned into an operating surplus in the first half of the fiscal year ending 2014/8. General Medical Research Holdings＜2385＞ 191 +29 East
Front market [stocks that have moved, stocks that have been created]
*Casio Calculator ＜6952＞ 1362.5 +66.5 No materials found, leading to buybacks and rising Citizens? *Citizen Watch ＜7762＞ 1038 +47 Jeffries Securities upgraded investment decisions. *Strong FA related movements such as Omron ＜6645＞ 5666 +255 FANUC and Yaskawa Electric. *Erex ＜9517＞ is it a sense of going all out of its way to sell it by hand due to the 724 +31 junction break? *Japan Material ＜6055＞ 2516 +107
List of Yunlou stocks [Ichimoku equilibrium table/ Yunlou stock list]
○Kumo Stock List Market Code Stock Name Closing Price Advance Span A Preceding Span B Tokyo Stock Exchange Prime ＜1808＞ Haseko 1926 1902 1885 ＜2288＞ Marudaishoku 1659 1654.75 1628.5 ＜2335＞ Cubesys 1124 1117.5 1105.5 ＜2502＞ Asa
Santen Pharmaceutical to Cancel 12 Million Treasury Shares
Santen Pharmaceutical (TYO:4536) will cancel 12 million treasury shares representing 3.2% of its outstanding shares on Friday, according to a Tokyo bourse filing on Monday. The drugmaker has completed
Express News | Santen Pharmaceutical completed and delivered a newly built eye drop plant in Suzhou Industrial Park
Santen Pharmaceutical's Returns to the Black in Fiscal Nine Months
Santen Pharmaceutical (TYO:4536) returned to the black with a profit attributable to owners of the parent of 26.61 billion yen in the fiscal nine months ended Dec. 31, 2023, from a loss of 16.06 billi
Santen Pharmaceutical Reports Q3 Results
Santen Pharmaceutical 9-Mos Net Y26.61B Vs Loss Y16.06B
Santen Pharmaceutical Co. Ltd. (4536.TO) Japan Nine Months Ended December 31 GROUP 2023 2022 Revenue Y222.83 bln Y199.79 bln Operating Profi
Jefferies Adjusts Santen Pharmaceutical's Price Target to 1,700 Yen From 1,650 Yen, Keeps at Buy
05:09 AM EST, 01/29/2024 (MT Newswires) -- Jefferies Adjusts Santen Pharmaceutical's Price Target to 1,700 Yen From 1,650 Yen, Keeps at Buy
Santen Pharmaceutical Further Repurchases Shares for Over 1 Billion Yen
Santen Pharmaceutical (TYO:4536) repurchased another 904,100 shares worth 1.24 billion yen in the open market from Dec. 1 to 31, 2023, according to a Friday bourse filing. The ophthalmology products m
Santen Pharmaceutical Buys Back Nearly 2 Billion Yen of Shares
Santen Pharmaceutical (TYO:4536) repurchased 1.3 million shares in the open market for a total of 1.82 billion yen, according to a Friday bourse filing. The ophthalmology-focused drugmaker bought the
Santen Pharmaceutical Co., Ltd. GAAP EPS of ¥69.68, Revenue of ¥145.81B
Santen Pharmaceutical 1H Net Y19.28B Vs Loss Y22.04B
Santen Pharmaceutical Co. Ltd. (4536.TO) Japan 1st Half Ended September 30 GROUP 2023 2022 Revenue Y145.81 bln Y128.92 bln Operating Profit
Analysis
Price Target
No Data
